Atrial Fibrillation

Bisphosphonates Increase Risk of Incident AF

The good news? Bisphosphonates are highly effective treatment for osteoporosis, osteopenia, and the prevention of fractures. The bad? Bisphosphonates have been linked to the development of atrial fibrillation.


Atrial Fibrillation

A recent study found the lower cost to be the result of fewer episodes of major bleeding in patients treated with apixaban.

Post-hoc analysis of the ENGAGE AF-TIMI 48 study looked at safety and efficacy of a novel oral anticoagulant in distinct groups with paroxysmal, persistent, or permanent atrial fibrillation.

A new study finds that ablation for atrial flutter reduces hospital-based costs, symptoms, and risk of atrial fibrillation. For stroke risk? Continue anticoagulation.

. . . . And then there’s lipoprotein(a), a diagnostic puzzle that involves acute abdominal pain and a CT scan in a woman with a complicated medical history, and skin lesions that look like coins. 5 questions in all. . . .

A meta-analysis shows both IV and oral formulations pose a risk of arrhythmia, the former more so than the latter. But these are very effective drugs. What next?

Results from the CRYSTAL-AF study find that nearly one-third of patients who experience cryptogenic stroke may have undetected atrial fibrillation.

A recent white paper declares it time to abolish the ambiguous term. Given current knowledge of atrial fibrillation, the 60-year-old description serves only to confuse.


Subscribe to Atrial Fibrillation on [sitename]
Please Wait 20 seconds or click here to close